| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP6V1A MYH3 ABCA4 ABCF3 ABCA12 EIF4A3 LRRK2 CLPX RAB6C SEPTIN3 GBP4 GBP5 RAB7A KIF5B RAB6D PMS1 SEPTIN5 TOR1A FANCM ARF6 KIF13A DDX21 XRCC6 DNAH11 | 8.81e-07 | 775 | 199 | 24 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP6V1A MYH3 ABCA4 ABCF3 ABCA12 EIF4A3 LRRK2 CLPX RAB6C SEPTIN3 GBP4 GBP5 RAB7A KIF5B RAB6D PMS1 SEPTIN5 TOR1A FANCM ARF6 KIF13A DDX21 XRCC6 DNAH11 | 3.49e-06 | 839 | 199 | 24 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP6V1A MYH3 ABCA4 ABCF3 ABCA12 EIF4A3 LRRK2 CLPX RAB6C SEPTIN3 GBP4 GBP5 RAB7A KIF5B RAB6D PMS1 SEPTIN5 TOR1A FANCM ARF6 KIF13A DDX21 XRCC6 DNAH11 | 3.56e-06 | 840 | 199 | 24 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP6V1A MYH3 ABCA4 ABCF3 ABCA12 EIF4A3 LRRK2 CLPX RAB6C SEPTIN3 GBP4 GBP5 RAB7A KIF5B RAB6D PMS1 SEPTIN5 TOR1A FANCM ARF6 KIF13A DDX21 XRCC6 DNAH11 | 3.56e-06 | 840 | 199 | 24 | GO:0016818 |
| GeneOntologyMolecularFunction | sodium channel activity | 1.26e-05 | 52 | 199 | 6 | GO:0005272 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP6V1A MYH3 ABCA4 ABCF3 ABCA12 EIF4A3 CLPX KIF5B PMS1 TOR1A FANCM KIF13A DDX21 XRCC6 DNAH11 | 3.82e-05 | 441 | 199 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | RIPK1 LRRK2 RPS6KC1 KSR1 CAMK2A HTATIP2 KSR2 CIT MKNK1 GRK1 PIM3 IKBKE UHMK1 MAPK10 MAP3K2 | 4.34e-05 | 446 | 199 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1A MYH3 ABCA4 ABCF3 ABCA12 EIF4A3 CLPX KIF5B PMS1 MYO1H TOR1A MYO1B FANCM DNAH17 KIF13A DDX21 XRCC6 DNAH11 | 4.54e-05 | 614 | 199 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 9.88e-05 | 2 | 199 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 9.88e-05 | 2 | 199 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 9.88e-05 | 2 | 199 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 9.88e-05 | 2 | 199 | 2 | GO:0004354 | |
| GeneOntologyMolecularFunction | protein kinase activity | RIPK1 LRRK2 PTK2 RPS6KC1 KSR1 CAMK2A HTATIP2 KSR2 NRG2 CIT MKNK1 GRK1 PIM3 IKBKE UHMK1 MAPK10 MAP3K2 | 1.12e-04 | 600 | 199 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.82e-04 | 118 | 199 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | RIPK1 LRRK2 PFKFB3 PTK2 RPS6KC1 KSR1 CAMK2A HTATIP2 KSR2 NRG2 CIT MKNK1 GRK1 PIM3 IKBKE UHMK1 MAPK10 MAP3K2 | 2.74e-04 | 709 | 199 | 18 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine kinase activity | RIPK1 LRRK2 RPS6KC1 KSR1 CAMK2A KSR2 CIT MKNK1 PIM3 UHMK1 MAPK10 MAP3K2 | 2.98e-04 | 363 | 199 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | scaffold protein binding | 3.37e-04 | 93 | 199 | 6 | GO:0097110 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | LRRK2 SUCLG2 RAB6C SEPTIN3 GBP4 GBP5 GLUD1 GLUD2 RAB7A CNGB1 RAB6D SEPTIN5 ARF6 | 4.81e-04 | 439 | 199 | 13 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | LRRK2 SUCLG2 RAB6C SEPTIN3 GBP4 GBP5 GLUD1 GLUD2 RAB7A CNGB1 RAB6D SEPTIN5 ARF6 | 4.81e-04 | 439 | 199 | 13 | GO:0019001 |
| GeneOntologyMolecularFunction | oleic acid binding | 5.85e-04 | 4 | 199 | 2 | GO:0070538 | |
| GeneOntologyMolecularFunction | kinase activity | RIPK1 LRRK2 PFKFB3 PTK2 RPS6KC1 KSR1 CAMK2A HTATIP2 KSR2 NRG2 CIT MKNK1 GRK1 PIM3 IKBKE UHMK1 MAPK10 MAP3K2 | 6.61e-04 | 764 | 199 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | GTP binding | LRRK2 SUCLG2 RAB6C SEPTIN3 GBP4 GBP5 GLUD1 GLUD2 RAB7A RAB6D SEPTIN5 ARF6 | 6.62e-04 | 397 | 199 | 12 | GO:0005525 |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 7.12e-04 | 18 | 199 | 3 | GO:0015280 | |
| GeneOntologyMolecularFunction | NAD+ binding | 9.81e-04 | 20 | 199 | 3 | GO:0070403 | |
| GeneOntologyMolecularFunction | actin binding | MYH3 ACTR3C TRPC5 LRRK2 NEB PTK2 HPCA TAGLN CNN1 NEBL MYO1H MYO1B ACTR3B | 1.07e-03 | 479 | 199 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | RIPK1 LRRK2 PFKFB3 PTK2 RPS6KC1 KSR1 PARP9 CAMK2A HTATIP2 KSR2 NRG2 REV3L CIT MKNK1 GRK1 PIM3 IKBKE UHMK1 MAPK10 MAP3K2 | 1.15e-03 | 938 | 199 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 1.44e-03 | 6 | 199 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.66e-03 | 171 | 199 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.69e-03 | 24 | 199 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | ligase activity | 1.84e-03 | 174 | 199 | 7 | GO:0016874 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 1.87e-03 | 129 | 199 | 6 | GO:0035591 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 2.01e-03 | 7 | 199 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | L-leucine binding | 2.01e-03 | 7 | 199 | 2 | GO:0070728 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.04e-03 | 227 | 199 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | GTPase activity | ABCA4 LRRK2 RAB6C SEPTIN3 GBP4 GBP5 RAB7A RAB6D SEPTIN5 ARF6 | 2.30e-03 | 341 | 199 | 10 | GO:0003924 |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 2.39e-03 | 27 | 199 | 3 | GO:0004709 | |
| GeneOntologyBiologicalProcess | membrane docking | 2.31e-06 | 91 | 194 | 8 | GO:0022406 | |
| GeneOntologyBiologicalProcess | regulation of vesicle docking | 8.08e-06 | 5 | 194 | 3 | GO:0106020 | |
| GeneOntologyBiologicalProcess | organelle localization by membrane tethering | 1.55e-05 | 85 | 194 | 7 | GO:0140056 | |
| GeneOntologyBiologicalProcess | vesicle docking | 3.34e-05 | 65 | 194 | 6 | GO:0048278 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | ATP6V1A LRRK2 HPCA AP2M1 NRXN1 RAB7A SEPTIN5 CAMK2A TOR1A ARF6 MAPK10 STX11 | 5.52e-05 | 321 | 194 | 12 | GO:0099003 |
| GeneOntologyBiologicalProcess | vesicle docking involved in exocytosis | 5.64e-05 | 44 | 194 | 5 | GO:0006904 | |
| GeneOntologyBiologicalProcess | regulation of meiosis I | 6.60e-05 | 9 | 194 | 3 | GO:0060631 | |
| GeneOntologyBiologicalProcess | photoreceptor cell maintenance | 7.78e-05 | 47 | 194 | 5 | GO:0045494 | |
| GeneOntologyBiologicalProcess | regulation of endocytosis | ABR LRRK2 PTK2 HPCA AP2M1 C2 PLCG2 NECAB2 TOR1A ARF6 MCTP1 CD36 LRRTM2 | 8.48e-05 | 389 | 194 | 13 | GO:0030100 |
| GeneOntologyBiologicalProcess | protein kinase A signaling | 8.62e-05 | 48 | 194 | 5 | GO:0010737 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle docking | 8.80e-05 | 2 | 194 | 2 | GO:0099148 | |
| GeneOntologyBiologicalProcess | cellular response to type II interferon | 1.03e-04 | 114 | 194 | 7 | GO:0071346 | |
| GeneOntologyBiologicalProcess | neuron development | GABRB2 TRPC5 LAMA1 LRRK2 CDH23 NCAM1 ADGRV1 CSMD3 DSCAML1 PTK2 NRXN1 KIF5B ADGRF1 CNGB1 CAMK2A DOCK10 TOR1A LAMB1 LAMB3 CIT PREX2 GRK1 ARF6 ABI2 SLIT3 UHMK1 PBX1 PBX2 PBX3 | 1.09e-04 | 1463 | 194 | 29 | GO:0048666 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | MAN2A1 ABR ABCA12 EIF4A3 LAMA1 LRRK2 CDH23 DSCAML1 PTK2 RYR1 SERPINB5 SGPL1 SCN5A FHL1 ROGDI MUC19 LAMB1 LAMB3 CBS GRK1 ABI2 SLIT3 PBX1 PBX2 PBX3 DNAH11 | 1.52e-04 | 1269 | 194 | 26 | GO:0009887 |
| GeneOntologyBiologicalProcess | cytolysis | 1.69e-04 | 12 | 194 | 3 | GO:0019835 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 1.83e-04 | 88 | 194 | 6 | GO:0071277 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | ABR LRRK2 PTK2 HPCA AP2M1 NRXN1 RAB7A C2 KIF5B PLCG2 NECAB2 SEPTIN5 TOR1A ARF6 MCTP1 CD36 LRRTM2 | 1.98e-04 | 667 | 194 | 17 | GO:0060627 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle endocytosis | 2.19e-04 | 13 | 194 | 3 | GO:1900244 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TRPC5 LAMA1 LRRK2 CDH23 NCAM1 DSCAML1 PTK2 NRXN1 KIF5B CAMK2A DOCK10 LAMB1 LAMB3 CIT PREX2 GRK1 ABI2 SLIT3 | 2.59e-04 | 748 | 194 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 2.62e-04 | 3 | 194 | 2 | GO:0071691 | |
| GeneOntologyCellularComponent | dendrite cytoplasm | 1.54e-06 | 39 | 195 | 6 | GO:0032839 | |
| GeneOntologyCellularComponent | glutamatergic synapse | GABRB2 ABR ASIC1 EIF4A3 LRRK2 NCAM1 PTK2 HPCA AP2M1 NRXN1 RAB7A CAMK2A DOCK10 NRG2 GRIK1 GRIK2 ARF6 ABI2 LRRTM2 MAPK10 | 8.31e-05 | 817 | 195 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | laminin complex | 9.14e-05 | 10 | 195 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.45e-04 | 29 | 195 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | presynapse | GABRB2 ATP6V1A ASIC1 TRPC5 LRRK2 NCAM1 AP2M1 SEPTIN3 NRXN1 RAB7A CNGB1 ROGDI SEPTIN5 CAMK2A TOR1A GRIK1 GRIK2 ARF6 MCTP1 STX11 | 2.44e-04 | 886 | 195 | 20 | GO:0098793 |
| GeneOntologyCellularComponent | laminin-1 complex | 2.58e-04 | 3 | 195 | 2 | GO:0005606 | |
| GeneOntologyCellularComponent | axon | ABR TRPC5 LRRK2 NCAM1 DSCAML1 HPCA NRXN1 SCN5A KIF5B EXOC7 CNGB1 EXOC6 NECAB2 ROGDI SEPTIN5 CAMK2A TOR1A GRIK1 GRIK2 UHMK1 | 2.63e-04 | 891 | 195 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | Flemming body | 3.42e-04 | 36 | 195 | 4 | GO:0090543 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 5.85e-04 | 110 | 195 | 6 | GO:0120111 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | CFAP251 LRRK2 HPCA KIF5B CFAP70 CAMK2A GRIK2 DNAH17 UHMK1 DNAH11 | 8.20e-04 | 317 | 195 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | distal axon | TRPC5 LRRK2 NCAM1 NRXN1 KIF5B EXOC7 CNGB1 EXOC6 SEPTIN5 TOR1A GRIK1 GRIK2 | 8.26e-04 | 435 | 195 | 12 | GO:0150034 |
| GeneOntologyCellularComponent | somatodendritic compartment | ABR ASIC1 EIF4A3 TRPC5 LRRK2 NCAM1 PTK2 HPCA NRXN1 KIF5B DMWD NECAB2 ROGDI CAMK2A DOCK10 GRIK1 APOB GRIK2 CIT ABI2 UHMK1 ASS1 MAPK10 | 1.14e-03 | 1228 | 195 | 23 | GO:0036477 |
| GeneOntologyCellularComponent | actin-based cell projection | 1.24e-03 | 278 | 195 | 9 | GO:0098858 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 1.27e-03 | 6 | 195 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | postsynapse | GABRB2 ABR ASIC1 EIF4A3 PSMA7 LRRK2 NCAM1 PTK2 RPS6KC1 HPCA AP2M1 KIF5B CAMK2A DOCK10 GRIK1 GRIK2 ARF6 ABI2 LRRTM2 MAPK10 | 1.38e-03 | 1018 | 195 | 20 | GO:0098794 |
| Domain | PBC | 4.38e-06 | 4 | 194 | 3 | PF03792 | |
| Domain | PBX | 4.38e-06 | 4 | 194 | 3 | IPR005542 | |
| Domain | LCCL | 2.16e-05 | 6 | 194 | 3 | PS50820 | |
| Domain | LCCL | 2.16e-05 | 6 | 194 | 3 | SM00603 | |
| Domain | LCCL | 2.16e-05 | 6 | 194 | 3 | PF03815 | |
| Domain | LCCL | 2.16e-05 | 6 | 194 | 3 | IPR004043 | |
| Domain | - | 2.16e-05 | 6 | 194 | 3 | 2.170.130.20 | |
| Domain | Ser/Thr_kinase_AS | RIPK1 LRRK2 RPS6KC1 KSR1 CAMK2A KSR2 CIT MKNK1 GRK1 PIM3 IKBKE UHMK1 MAPK10 MAP3K2 | 2.30e-05 | 357 | 194 | 14 | IPR008271 |
| Domain | S_TKc | RIPK1 LRRK2 RPS6KC1 KSR1 CAMK2A KSR2 CIT MKNK1 GRK1 PIM3 IKBKE UHMK1 MAPK10 MAP3K2 | 2.44e-05 | 359 | 194 | 14 | SM00220 |
| Domain | P-loop_NTPase | ATP6V1A MYH3 ABCA4 ABCF3 ABCA12 EIF4A3 LRRK2 PFKFB3 CLPX RAB6C SEPTIN3 GBP4 GBP5 RAB7A KIF5B SEPTIN5 TOR1A MYO1B FANCM ARF6 KIF13A DDX21 DNAH11 | 2.52e-05 | 848 | 194 | 23 | IPR027417 |
| Domain | PROTEIN_KINASE_ST | RIPK1 LRRK2 RPS6KC1 KSR1 CAMK2A KSR2 CIT MKNK1 GRK1 PIM3 IKBKE UHMK1 MAPK10 MAP3K2 | 2.68e-05 | 362 | 194 | 14 | PS00108 |
| Domain | ELFV_dehydrog_N | 1.07e-04 | 2 | 194 | 2 | PF02812 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 1.07e-04 | 2 | 194 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 1.07e-04 | 2 | 194 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 1.07e-04 | 2 | 194 | 2 | IPR006095 | |
| Domain | KSR1-SAM | 1.07e-04 | 2 | 194 | 2 | PF13543 | |
| Domain | ELFV_dehydrog | 1.07e-04 | 2 | 194 | 2 | PF00208 | |
| Domain | NAD_bind_Glu_DH | 1.07e-04 | 2 | 194 | 2 | IPR033922 | |
| Domain | GLFV_DEHYDROGENASE | 1.07e-04 | 2 | 194 | 2 | PS00074 | |
| Domain | ELFV_dehydrog | 1.07e-04 | 2 | 194 | 2 | SM00839 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 1.07e-04 | 2 | 194 | 2 | IPR033524 | |
| Domain | KSR_SAM-like_dom | 1.07e-04 | 2 | 194 | 2 | IPR025561 | |
| Domain | Pkinase | RIPK1 LRRK2 RPS6KC1 CAMK2A KSR2 CIT MKNK1 GRK1 PIM3 IKBKE UHMK1 MAPK10 MAP3K2 | 1.82e-04 | 381 | 194 | 13 | PF00069 |
| Domain | Prot_kinase_dom | RIPK1 LRRK2 PTK2 RPS6KC1 KSR1 CAMK2A KSR2 CIT MKNK1 GRK1 PIM3 IKBKE UHMK1 MAPK10 MAP3K2 | 1.88e-04 | 489 | 194 | 15 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | RIPK1 LRRK2 PTK2 RPS6KC1 KSR1 CAMK2A KSR2 CIT MKNK1 GRK1 PIM3 IKBKE UHMK1 MAPK10 MAP3K2 | 2.06e-04 | 493 | 194 | 15 | PS50011 |
| Domain | - | ATP6V1A ABCA4 ABCF3 ABCA12 EIF4A3 LRRK2 PFKFB3 CLPX RAB6C SEPTIN3 GBP4 GBP5 RAB7A SEPTIN5 TOR1A FANCM ARF6 DDX21 DNAH11 | 2.95e-04 | 746 | 194 | 19 | 3.40.50.300 |
| Domain | Arp3_met | 3.20e-04 | 3 | 194 | 2 | IPR015623 | |
| Domain | Kinase-like_dom | RIPK1 LRRK2 PTK2 RPS6KC1 KSR1 CAMK2A KSR2 CIT MKNK1 GRK1 PIM3 IKBKE UHMK1 MAPK10 MAP3K2 | 5.58e-04 | 542 | 194 | 15 | IPR011009 |
| Domain | Laminin_N | 5.59e-04 | 16 | 194 | 3 | IPR008211 | |
| Domain | LamNT | 5.59e-04 | 16 | 194 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 5.59e-04 | 16 | 194 | 3 | PS51117 | |
| Domain | Laminin_N | 5.59e-04 | 16 | 194 | 3 | PF00055 | |
| Domain | Nebulin | 6.35e-04 | 4 | 194 | 2 | PF00880 | |
| Domain | NEBULIN | 6.35e-04 | 4 | 194 | 2 | PS51216 | |
| Domain | NEBU | 6.35e-04 | 4 | 194 | 2 | SM00227 | |
| Domain | Nebulin | 6.35e-04 | 4 | 194 | 2 | IPR013998 | |
| Domain | Nebulin_repeat | 6.35e-04 | 4 | 194 | 2 | IPR000900 | |
| Domain | - | 1.05e-03 | 5 | 194 | 2 | 2.40.290.10 | |
| Domain | SPOC-like_C_dom | 1.05e-03 | 5 | 194 | 2 | IPR016194 | |
| Domain | Calponin_repeat | 1.57e-03 | 6 | 194 | 2 | IPR000557 | |
| Domain | Calponin | 1.57e-03 | 6 | 194 | 2 | PF00402 | |
| Domain | CALPONIN_1 | 1.57e-03 | 6 | 194 | 2 | PS01052 | |
| Domain | CALPONIN_2 | 1.57e-03 | 6 | 194 | 2 | PS51122 | |
| Pubmed | GABRB2 DOCK4 ATP6V1A ACTR3C NCAM1 BIRC6 RPS6KC1 HPCA ESYT2 SERPINB5 AP2M1 SEPTIN3 NRXN1 GLUD1 GLUD2 RAB7A KIF5B UQCRC2 FHL1 MIA3 SEPTIN5 DNAJC16 CAMK2A NUP88 ACTR3B CIT ABI2 SNX25 PDE4DIP PC | 3.91e-12 | 1139 | 200 | 30 | 36417873 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | WBP2 ABCF3 UGGT1 PSMA7 PFKFB3 CLPX SUCLG2 DDB1 MRPS22 PGM1 NLN ESYT2 SERPINB5 AP2M1 PELO GLUD1 SCP2 RAB7A PARP9 KIF5B TAGLN FHL1 KNL1 NPLOC4 MARCHF5 PC DDX21 XRCC6 | 6.11e-09 | 1367 | 200 | 28 | 32687490 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ATP6V1A ABCF3 EIF4A3 UGGT1 PSMA7 PABPC4 RBM26 PSMD9 CLPX BIRC6 DDB1 MRPS22 AP2M1 SARS1 PELO GLUD1 SELENOF KIF5B UQCRC2 FARSB CBS NPLOC4 PAXBP1 ASS1 SCAF11 PC DDX21 XRCC6 | 1.28e-08 | 1415 | 200 | 28 | 28515276 |
| Pubmed | ABCF3 MAN2A1 ABR EIF4A3 NCAM1 BIRC6 KSR1 ESYT2 GBP5 SCP2 PARP9 KIF5B MED17 EXOC7 ZDHHC13 MIA3 CNOT10 HTATIP2 DOCK10 FARSB CIT ARF6 MARCHF5 DDX21 XRCC6 | 1.84e-08 | 1168 | 200 | 25 | 19946888 | |
| Pubmed | MYH3 PDE6A EIF4A3 UGGT1 PSMA7 PABPC4 CLPX NEB PSMA8 RPS6KC1 HPCA AP2M1 NRXN1 GLUD1 GLUD2 KIF5B UQCRC2 DMWD SKAP2 MYO1B APOB PCF11 SNX25 OGDHL DDX21 SPEN XRCC6 SLC6A14 | 1.91e-08 | 1442 | 200 | 28 | 35575683 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GABRB2 ATP6V1A MYH3 MAN2A1 VPS13C LRRK2 PEPD ADGRV1 NEB DDB1 PGM1 RYR1 CEMIP2 SERPINA1 AP2M1 BEND7 RAB7A CFAP70 NEBL MYO1B SUSD2 ASS1 SPEN | 2.59e-08 | 1016 | 200 | 23 | 19056867 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DOCK4 UGGT1 PSMA7 PABPC4 PFKFB3 CLPX MRPS22 PTK2 SARS1 PELO RAB7A KIF5B UQCRC2 TAGLN MMS22L CAMK2A CNOT10 TOR1A MYO1B ACTR3B NXN ARF6 IKBKE SUSD2 DDX21 MAP3K2 | 2.83e-08 | 1284 | 200 | 26 | 17353931 |
| Pubmed | WBP2 EIF4A3 DSCAML1 PTK2 AP2M1 FBN1 SEPTIN3 GLUD1 ZNF841 EXOC7 FHL1 COG4 CAMK2A LAMB1 GRIK1 ACTR3B REV3L CIT CBS PDE4DIP ZNF76 PBX1 PBX2 PBX3 PC XRCC6 | 2.87e-08 | 1285 | 200 | 26 | 35914814 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP6V1A EIF4A3 VPS13C UGGT1 PSMA7 PABPC4 RBM26 PEPD CLPX DDB1 AP2M1 SARS1 GLUD1 RAB7A KIF5B UQCRC2 FHL1 NUP88 FARSB MYO1B APOB CBS PAXBP1 PC DDX21 SPEN XRCC6 | 5.79e-08 | 1425 | 200 | 27 | 30948266 |
| Pubmed | ATP6V1A ACTR3C PSMA7 PABPC4 NCAM1 DDB1 MRPS22 PGM1 HPCA AP2M1 SARS1 SGPL1 GLUD1 GLUD2 RAB7A KIF5B UQCRC2 FHL1 SEPTIN5 CAMK2A FARSB ACTR3B CIT PDE4DIP OGDHL PC DNAH11 | 6.31e-08 | 1431 | 200 | 27 | 37142655 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | UGGT1 SUCLG2 DDB1 GLUD1 GLUD2 RAB7A FARSB CIT PREX2 DDX21 XRCC6 | 9.05e-08 | 226 | 200 | 11 | 37839992 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MAN2A1 UGGT1 LAMA1 DCBLD1 DDB1 MRPS22 CEMIP2 ITFG1 FBN1 COCH SGPL1 SELENOF SLC35A2 TXNDC16 TTC13 KIF5B ZDHHC13 MIA3 DNAJC16 HTATIP2 TOR1A LAMB1 LAMB3 GRIK2 | 1.29e-07 | 1201 | 200 | 24 | 35696571 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATP6V1A ABR ACTR3C VPS13C HDAC8 PEPD ADGRV1 PTK2 ITFG1 ESYT2 SCP2 RAB7A ZDHHC13 MIA3 SEPTIN5 KSR2 GRIK1 GRIK2 NXN NAALADL2 SNX29 NPLOC4 ASS1 SCAF11 PBX1 PBX2 PBX3 | 1.40e-07 | 1489 | 200 | 27 | 28611215 |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | ATP6V1A RIPK1 PABPC4 AP2M1 FBN1 RAB7A NUP88 TOR1A CIT ARF6 PDE4DIP DDX21 | 1.83e-07 | 298 | 200 | 12 | 32353859 |
| Pubmed | The TALE homeodomain protein Pbx2 is not essential for development and long-term survival. | 1.87e-07 | 3 | 200 | 3 | 15169896 | |
| Pubmed | 1.87e-07 | 3 | 200 | 3 | 10679934 | ||
| Pubmed | 1.87e-07 | 3 | 200 | 3 | 11468159 | ||
| Pubmed | 2.65e-07 | 152 | 200 | 9 | 34299191 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ATP6V1A EIF4A3 UGGT1 PSMA7 PABPC4 PSMD9 CLPX BIRC6 DDB1 ESYT2 AP2M1 PELO GLUD1 GLUD2 KIF5B UQCRC2 MED17 SKAP2 FARSB MYO1B CBS NPLOC4 DDX21 XRCC6 | 2.94e-07 | 1257 | 200 | 24 | 37317656 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | ATP6V1A ABR EIF4A3 LAMA1 CLPX LPIN1 ESYT2 PELO SGPL1 MYO1B PAXBP1 SPEN | 3.10e-07 | 313 | 200 | 12 | 38270169 |
| Pubmed | MYH3 RIPK1 UGGT1 HDAC8 PTGR2 NEB RYR1 LPIN1 SERPINA1 SARS1 SGPL1 PARP9 KIF5B PLCG2 CRISPLD1 COG4 CCDC33 HTATIP2 LAMB3 REV3L CD36 PDE4DIP OGDHL PBX3 | 4.87e-07 | 1293 | 200 | 24 | 15342556 | |
| Pubmed | 5.07e-07 | 12 | 200 | 4 | 9396756 | ||
| Pubmed | UGGT1 PSMD9 ESYT2 COCH SARS1 GLUD1 GLUD2 RAB7A EXOC7 EXOC6 DNAJC16 NUP88 MYO1B CBS PC XRCC6 | 5.24e-07 | 606 | 200 | 16 | 36538041 | |
| Pubmed | EIF4A3 PSMA7 PABPC4 SUCLG2 DDB1 MRPS22 SGPL1 KIF5B FARSB LAMB3 CBS PCF11 DDX21 XRCC6 | 6.55e-07 | 469 | 200 | 14 | 37314180 | |
| Pubmed | Pbx/Meis deficiencies demonstrate multigenetic origins of congenital heart disease. | 7.46e-07 | 4 | 200 | 3 | 18723445 | |
| Pubmed | PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. | 7.46e-07 | 4 | 200 | 3 | 1682799 | |
| Pubmed | ATP6V1A ABCA4 PDE6A NCAM1 PGM1 SERPINA1 AP2M1 SARS1 GLUD1 GLUD2 KIF5B UQCRC2 MYO1B GRK1 ASS1 | 8.40e-07 | 552 | 200 | 15 | 36293380 | |
| Pubmed | DOCK4 UGGT1 PABPC4 CLPX MRPS22 SERPINB5 AP2M1 SARS1 SGPL1 PMS1 FARSB LAMB3 MYO1B SCAF11 DDX21 XRCC6 | 9.46e-07 | 634 | 200 | 16 | 34591612 | |
| Pubmed | WBP2 ATP6V1A ABCF3 EIF4A3 PABPC4 DDB1 MRPS22 AP2M1 SARS1 PELO GLUD1 RAB7A KIF5B MED17 NEBL FARSB LAMB1 MYO1B CIT PAXBP1 ASS1 DDX21 XRCC6 | 9.56e-07 | 1247 | 200 | 23 | 27684187 | |
| Pubmed | VPS13C UGGT1 RBM26 BIRC6 DDB1 CEMIP2 SLC35D1 AP2M1 FBXO5 SGPL1 TTC13 EXOC7 COG4 KNL1 MIA3 NEBL DNAJC16 | 1.36e-06 | 733 | 200 | 17 | 34672954 | |
| Pubmed | ATP6V1A UGGT1 PABPC4 RBM26 CLPX SUCLG2 DDB1 PSMA8 AP2M1 RAB7A KIF5B UQCRC2 ASNSD1 FARSB MYO1B APOB NPLOC4 ARF6 PCF11 PAXBP1 SCAF11 PC DDX21 XRCC6 | 1.36e-06 | 1371 | 200 | 24 | 36244648 | |
| Pubmed | Transcription factor PBX4 regulates limb development and haematopoiesis in mice. | 1.86e-06 | 5 | 200 | 3 | 38230761 | |
| Pubmed | 1.86e-06 | 5 | 200 | 3 | 10842069 | ||
| Pubmed | Pbx4, a new Pbx family member on mouse chromosome 8, is expressed during spermatogenesis. | 1.86e-06 | 5 | 200 | 3 | 11335119 | |
| Pubmed | HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. | 1.86e-06 | 5 | 200 | 3 | 10082572 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATP6V1A RBM26 PEPD DDB1 AP2M1 GLUD1 KIF5B KNL1 PMS1 NEBL NUP88 FARSB MYO1B CBS SNX29 NPLOC4 PC DDX21 XRCC6 | 2.20e-06 | 934 | 200 | 19 | 33916271 |
| Pubmed | CLPX DDB1 PGM1 ESYT2 SARS1 KIF5B NUP88 DOCK10 FARSB CBS NPLOC4 DDX21 XRCC6 | 2.43e-06 | 451 | 200 | 13 | 36168627 | |
| Pubmed | Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation. | 2.73e-06 | 68 | 200 | 6 | 25754235 | |
| Pubmed | ASIC1 EIF4A3 UGGT1 NCAM1 BIRC6 RAB6C CEMIP2 ESYT2 AP2M1 SGPL1 GLUD1 SLC35A2 GLUD2 RAB7A UQCRC2 ZDHHC13 MIA3 DNAJC16 ARF6 | 2.90e-06 | 952 | 200 | 19 | 38569033 | |
| Pubmed | ABR ASIC1 NCAM1 DDB1 PTK2 SEPTIN3 NRXN1 RAB7A KIF5B MIA3 SEPTIN5 CAMK2A KSR2 FARSB GRIK2 CIT ABI2 PDE4DIP XRCC6 | 3.42e-06 | 963 | 200 | 19 | 28671696 | |
| Pubmed | The PBX-regulating protein PREP1 is present in different PBX-complexed forms in mouse. | 3.70e-06 | 6 | 200 | 3 | 10381567 | |
| Pubmed | Characterization of TALE genes expression during the first lineage segregation in mammalian embryos. | 3.70e-06 | 6 | 200 | 3 | 22987645 | |
| Pubmed | Expression and localization of laminin-5 subunits in the mouse incisor. | 3.70e-06 | 6 | 200 | 3 | 9506922 | |
| Pubmed | ABCF3 PTK2 CEMIP2 RPS6KC1 GLUD1 RAB7A KIF5B FHL1 MUC19 SNX29 GPR176 | 4.85e-06 | 339 | 200 | 11 | 37232246 | |
| Pubmed | UGGT1 PSMA7 CLPX DDB1 MRPS22 CEMIP2 ESYT2 COCH SARS1 GLUD1 SELENOF RAB7A TTC13 UQCRC2 PMS1 MIA3 DNAJC16 TOR1A LAMB1 SNX29 PCF11 PAXBP1 DDX21 XRCC6 | 5.45e-06 | 1487 | 200 | 24 | 33957083 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH3 UGGT1 PSMA7 PABPC4 SUCLG2 PSMA8 ESYT2 SERPINA1 UQCRC2 EXOC7 FHL1 LAMB3 MYO1B ACTR3B PCF11 | 5.82e-06 | 647 | 200 | 15 | 26618866 |
| Pubmed | 6.45e-06 | 7 | 200 | 3 | 19498109 | ||
| Pubmed | Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. | 6.45e-06 | 7 | 200 | 3 | 9390664 | |
| Pubmed | 6.45e-06 | 7 | 200 | 3 | 12397630 | ||
| Pubmed | LONP1-mediated mitochondrial quality control safeguards metabolic shifts in heart development. | 6.77e-06 | 46 | 200 | 5 | 35237793 | |
| Pubmed | KANSL1L MYH3 MYOM1 NEB SUCLG2 BIRC6 PGM1 RYR1 FHL1 SKAP2 CCDC141 PDE4DIP XRCC6 | 6.95e-06 | 497 | 200 | 13 | 23414517 | |
| Pubmed | ATP6V1A PSMA7 PABPC4 PFKFB3 BIRC6 DDB1 ESYT2 RAB7A EXOC7 MMS22L DNAJC16 TOR1A LAMB1 NPLOC4 DDX21 | 6.98e-06 | 657 | 200 | 15 | 36180527 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ATP6V1A RIPK1 UGGT1 PABPC4 PSMD9 DDB1 AP2M1 FBN1 RAB7A NUP88 TOR1A CIT ARF6 MARCHF5 PDE4DIP DDX21 | 8.56e-06 | 754 | 200 | 16 | 33060197 |
| Pubmed | PSMA7 PABPC4 CLPX DDB1 MRPS22 AP2M1 FBN1 GLUD1 RAB7A UQCRC2 MED17 FHL1 ASNSD1 CNOT10 NUP88 MYO1B CIT PCF11 SCAF11 PBX1 PBX2 SPEN XRCC6 | 9.07e-06 | 1429 | 200 | 23 | 35140242 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 1.03e-05 | 8 | 200 | 3 | 9489770 | |
| Pubmed | 1.03e-05 | 8 | 200 | 3 | 31625560 | ||
| Pubmed | GluD1 is a signal transduction device disguised as an ionotropic receptor. | 1.03e-05 | 8 | 200 | 3 | 34135511 | |
| Pubmed | 1.15e-05 | 87 | 200 | 6 | 20801516 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ATP6V1A UGGT1 PSMA7 PABPC4 RBM26 PSMD9 DDB1 MRPS22 PGM1 AP2M1 SARS1 PELO GLUD1 RAB7A KIF5B EXOC7 FHL1 FARSB MYO1B XRCC6 | 1.19e-05 | 1149 | 200 | 20 | 35446349 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | UGGT1 RBM26 DDB1 MRPS22 ESYT2 SERPINA1 AP2M1 GLUD1 RAB7A TXNDC16 TTC13 UQCRC2 ASNSD1 DNAJC16 NUP88 FARSB LAMB1 NPLOC4 | 1.51e-05 | 974 | 200 | 18 | 28675297 |
| Pubmed | Meis homeoproteins directly regulate Pax6 during vertebrate lens morphogenesis. | 1.53e-05 | 9 | 200 | 3 | 12183364 | |
| Pubmed | A highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscle. | 1.53e-05 | 9 | 200 | 3 | 18676817 | |
| Pubmed | 1.64e-05 | 251 | 200 | 9 | 27507650 | ||
| Pubmed | ATP6V1A EIF4A3 VPS13C PABPC4 SUCLG2 AP2M1 RAB7A KIF5B UQCRC2 FARSB MYO1B NPLOC4 ARF6 DDX21 XRCC6 MAP3K2 | 1.85e-05 | 803 | 200 | 16 | 36517590 | |
| Pubmed | PSMA7 RBM26 CLPX DDB1 MRPS22 AP2M1 PELO SGPL1 GLUD1 FARSB CBS PC DDX21 | 1.91e-05 | 547 | 200 | 13 | 37267103 | |
| Pubmed | ATP6V1A MAN2A1 EIF4A3 UGGT1 PABPC4 PSMD9 CLPX BIRC6 AP2M1 RAB7A TTC13 UQCRC2 MIA3 TOR1A FARSB LAMB1 MYO1B APOB CBS ASS1 XRCC6 | 2.09e-05 | 1297 | 200 | 21 | 33545068 | |
| Pubmed | LRRK2 ADGRV1 MRPS22 CSAD CCDC33 PMS1 GLB1L3 CAMK2A HTATIP2 MYO1B GRIK2 ACTR3B NAALADL2 CBS SNX29 PCF11 | 2.18e-05 | 814 | 200 | 16 | 23251661 | |
| Pubmed | A unique stylopod patterning mechanism by Shox2-controlled osteogenesis. | 2.18e-05 | 10 | 200 | 3 | 27287812 | |
| Pubmed | 2.18e-05 | 10 | 200 | 3 | 9034910 | ||
| Pubmed | ATP6V1A UGGT1 RBM26 DDB1 ESYT2 AP2M1 SGPL1 UQCRC2 MED17 EXOC7 CNOT10 NUP88 MYO1B | 2.44e-05 | 560 | 200 | 13 | 35241646 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | ATP6V1A EIF4A3 PSMA7 PSMA8 MRPS22 RYR1 ESYT2 SERPINA1 SERPINB5 AP2M1 RAB7A DNAJC16 KSR2 CIT DDX21 | 2.47e-05 | 732 | 200 | 15 | 34732716 |
| Pubmed | CLPX PTK2 CEMIP2 LPIN1 SGPL1 UQCRC2 EXOC7 COG4 PMS1 MIA3 DNAJC16 DOCK10 LAMB3 NPLOC4 | 2.70e-05 | 650 | 200 | 14 | 38777146 | |
| Pubmed | 2.70e-05 | 101 | 200 | 6 | 18519826 | ||
| Pubmed | ABCF3 ASIC1 PABPC4 RBM26 CLPX DDB1 ESYT2 AP2M1 PELO KIF5B UQCRC2 FHL1 OGDHL XRCC6 | 2.84e-05 | 653 | 200 | 14 | 33742100 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 2.99e-05 | 11 | 200 | 3 | 23472759 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 2.99e-05 | 11 | 200 | 3 | 21524702 | |
| Pubmed | ATP6V1A PSMA7 PTGR2 NCAM1 DDB1 GLUD1 NECAB2 CAMK2A CIT XRCC6 | 3.12e-05 | 341 | 200 | 10 | 29791485 | |
| Pubmed | ATP6V1A UGGT1 PSMA7 PABPC4 PFKFB3 CLPX SUCLG2 DDB1 MRPS22 ESYT2 AP2M1 PELO SGPL1 SELENOF UQCRC2 EXOC7 COG4 FARSB LAMB1 MYO1B NPLOC4 XRCC6 | 3.17e-05 | 1440 | 200 | 22 | 30833792 | |
| Pubmed | CDH23 PFKFB3 SGPL1 BEND7 GLUD1 KIF5B CFAP70 EXOC6 NEBL OGDHL DDX21 | 3.17e-05 | 415 | 200 | 11 | 16385451 | |
| Pubmed | EIF4A3 UGGT1 PSMA7 PABPC4 PSMD9 DDB1 PSMA8 MRPS22 PELO UQCRC2 MED17 DNAJC16 NUP88 FARSB ACTR3B NXN CBS NPLOC4 PC DDX21 XRCC6 | 3.18e-05 | 1335 | 200 | 21 | 29229926 | |
| Pubmed | Kinase suppressor of Ras 2 (KSR2) regulates tumor cell transformation via AMPK. | 3.29e-05 | 2 | 200 | 2 | 22801368 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 28621566 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 15121855 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 32078638 | ||
| Pubmed | CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding. | 3.29e-05 | 2 | 200 | 2 | 25555908 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 14724198 | ||
| Pubmed | Interaction of glutamic-acid-rich proteins with the cGMP signalling pathway in rod photoreceptors. | 3.29e-05 | 2 | 200 | 2 | 10466724 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 15539395 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 28911206 | ||
| Pubmed | Molecular basis of human glutamate dehydrogenase regulation under changing energy demands. | 3.29e-05 | 2 | 200 | 2 | 15578726 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 29549916 | ||
| Pubmed | Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. | 3.29e-05 | 2 | 200 | 2 | 8260617 | |
| Pubmed | Induction of excitatory and inhibitory presynaptic differentiation by GluD1. | 3.29e-05 | 2 | 200 | 2 | 22138648 | |
| Pubmed | Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses. | 3.29e-05 | 2 | 200 | 2 | 15537878 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 21051832 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 28667800 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 15358807 | ||
| Pubmed | Potentiation of neuronal activity by tonic GluD1 current in brain slices. | 3.29e-05 | 2 | 200 | 2 | 37154294 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 26785044 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 19851499 | ||
| Interaction | CALR3 interactions | UGGT1 ADGRV1 BIRC6 SELENOF TXNDC16 TTC13 UQCRC2 MIA3 TOR1A LAMB1 | 1.51e-06 | 142 | 199 | 10 | int:CALR3 |
| Cytoband | 12q12 | 5.38e-05 | 47 | 200 | 4 | 12q12 | |
| GeneFamily | Laminin subunits | 9.30e-05 | 12 | 139 | 3 | 626 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 5.78e-04 | 5 | 139 | 2 | 1199 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 5.78e-04 | 5 | 139 | 2 | 1157 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 1.02e-03 | 26 | 139 | 3 | 526 | |
| GeneFamily | Myosins, class I | 1.59e-03 | 8 | 139 | 2 | 1097 | |
| GeneFamily | BEN domain containing | 2.04e-03 | 9 | 139 | 2 | 422 | |
| GeneFamily | Exocyst complex | 2.04e-03 | 9 | 139 | 2 | 1055 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.77e-03 | 181 | 139 | 6 | 694 | |
| GeneFamily | Septins | 4.33e-03 | 13 | 139 | 2 | 732 | |
| GeneFamily | Proteasome | 4.38e-03 | 43 | 139 | 3 | 690 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GABRB2 DOCK4 ABR LRRK2 RBM26 NCAM1 NEB CSMD3 DSCAML1 LPIN1 NLN NRXN1 CSAD GOLGA7B MIA3 DNAJC16 KSR2 MUC19 GRIK1 GRIK2 REV3L CCDC141 PDE4DIP LRRTM2 OGDHL PBX3 KIF13A GPR176 CCDC144A MAP3K2 | 1.44e-09 | 1106 | 199 | 30 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | GABRB2 DOCK4 NCAM1 CSMD3 LPIN1 NLN NRXN1 CSAD SCN7A GOLGA7B CNGB1 KSR2 MUC19 NRG2 GRIK2 REV3L PDE4DIP OGDHL PBX3 GPR176 CCDC144A | 1.05e-07 | 703 | 199 | 21 | M39070 |
| Coexpression | GABRIELY_MIR21_TARGETS | UGGT1 RAB6C CEMIP2 LPIN1 ESYT2 PARP9 KNL1 DOCK10 REV3L SCAF11 PBX1 MAP3K2 | 2.37e-06 | 289 | 199 | 12 | M2196 |
| Coexpression | GSE10325_MYELOID_VS_LUPUS_MYELOID_UP | 2.73e-06 | 196 | 199 | 10 | M3096 | |
| Coexpression | HALLMARK_MYOGENESIS | 3.27e-06 | 200 | 199 | 10 | M5909 | |
| Coexpression | LEI_HOXC8_TARGETS_DN | 7.10e-06 | 17 | 199 | 4 | M1404 | |
| Coexpression | LEI_HOXC8_TARGETS_DN | 7.10e-06 | 17 | 199 | 4 | MM610 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN | ABCA12 LAMA1 DCBLD1 SERPINA1 BEND7 CFAP70 SUSD2 ASS1 SLC6A14 | 8.13e-06 | 175 | 199 | 9 | M6750 |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 9.24e-06 | 225 | 199 | 10 | M6175 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 1.56e-05 | 239 | 199 | 10 | MM1274 | |
| Coexpression | GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP | 2.18e-05 | 198 | 199 | 9 | M7684 | |
| Coexpression | GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP | 2.36e-05 | 200 | 199 | 9 | M8550 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | NPL LRRK2 DCBLD1 PFKFB3 RPS6KC1 KSR1 NLN SERPINA1 GBP4 GBP5 C2 PARP9 TAGLN SKAP2 EXOC6 MIA3 ROGDI PIM3 MCTP1 CD36 STX11 | 3.14e-05 | 1012 | 199 | 21 | M40868 |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 3.15e-05 | 48 | 199 | 5 | M16123 | |
| Coexpression | ZAMORA_NOS2_TARGETS_DN | 3.85e-05 | 82 | 199 | 6 | M1638 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | DOCK4 NCAM1 CSMD3 LPIN1 NLN SEPTIN3 NRXN1 GOLGA7B KSR2 REV3L PDE4DIP LRRTM2 PBX1 PBX3 GPR176 | 4.35e-05 | 584 | 199 | 15 | M39068 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | GABRB2 ASIC1 NCAM1 LPIN1 NLN SEPTIN3 NRXN1 CNGB1 DNAJC16 KSR2 MUC19 LRRTM2 PBX3 | 6.08e-05 | 465 | 199 | 13 | M39066 |
| Coexpression | ZAMORA_NOS2_TARGETS_DN | 6.11e-05 | 89 | 199 | 6 | MM690 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | LAMA1 TAGLN FHL1 DMWD CRISPLD1 CNN1 DOCK10 LAMB1 LAMB3 NXN CD36 SLIT3 GPR176 | 8.19e-05 | 479 | 199 | 13 | M2573 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | DOCK4 EIF4A3 LRRK2 PFKFB3 NR6A1 MRPS22 ITFG1 RPS6KC1 KSR1 FBN1 TXNDC16 KIF5B PLCG2 SKAP2 LAMB3 SNX29 PIM3 MCTP1 SLC16A5 KIF13A DDX21 STX11 MAP3K2 | 8.24e-05 | 1250 | 199 | 23 | M41099 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | LAMA1 TAGLN FHL1 DMWD CRISPLD1 CNN1 DOCK10 LAMB1 LAMB3 NXN CD36 SLIT3 GPR176 | 8.90e-05 | 483 | 199 | 13 | MM1082 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | MAN2A1 ACTR3C NCAM1 SUCLG2 DDB1 PGM1 RPS6KC1 ESYT2 SARS1 KIF5B UQCRC2 DOCK10 FARSB LAMB3 SNX29 PDE4DIP ASS1 PBX1 STX11 MAP3K2 | 9.15e-05 | 1009 | 199 | 20 | M157 |
| Coexpression | GSE3982_NKCELL_VS_TH1_UP | 1.28e-04 | 195 | 199 | 8 | M5593 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP | 1.38e-04 | 197 | 199 | 8 | M8426 | |
| Coexpression | JIANG_AGING_HYPOTHALAMUS_DN | 1.40e-04 | 35 | 199 | 4 | M1535 | |
| Coexpression | JIANG_AGING_HYPOTHALAMUS_DN | 1.40e-04 | 35 | 199 | 4 | MM656 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 1.42e-04 | 198 | 199 | 8 | MM17083 | |
| Coexpression | GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP | 1.47e-04 | 199 | 199 | 8 | M7967 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 1.47e-04 | 199 | 199 | 8 | M9236 | |
| Coexpression | HOWARD_B_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 1.48e-04 | 14 | 199 | 3 | M41166 | |
| Coexpression | GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN | 1.53e-04 | 200 | 199 | 8 | M3416 | |
| Coexpression | GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP | 1.53e-04 | 200 | 199 | 8 | M3431 | |
| Coexpression | GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP | 1.53e-04 | 200 | 199 | 8 | M7279 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP | 1.53e-04 | 200 | 199 | 8 | M7471 | |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 1.53e-04 | 200 | 199 | 8 | M78 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP | 1.53e-04 | 200 | 199 | 8 | M5131 | |
| Coexpression | GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP | 1.53e-04 | 200 | 199 | 8 | M7894 | |
| Coexpression | GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN | 1.53e-04 | 200 | 199 | 8 | M7814 | |
| Coexpression | HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP | DOCK4 LRRK2 PFKFB3 SERPINA1 GBP4 GBP5 C2 PARP9 MCTP1 CD36 STX11 | 1.56e-04 | 377 | 199 | 11 | M40997 |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL | DOCK4 PFKFB3 PGM1 KIF5B TAGLN FHL1 LAMB3 MYO1B NXN SUSD2 STX11 | 2.13e-04 | 391 | 199 | 11 | M41659 |
| Coexpression | KUMAR_AUTOPHAGY_NETWORK | 2.22e-04 | 72 | 199 | 5 | M2539 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP | 2.38e-04 | 161 | 199 | 7 | M9446 | |
| Coexpression | GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP | 2.38e-04 | 161 | 199 | 7 | M7728 | |
| Coexpression | GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN | 2.67e-04 | 164 | 199 | 7 | M8989 | |
| Coexpression | GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP | 2.77e-04 | 165 | 199 | 7 | M6880 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GABRB2 ABCA4 ABCA12 LAMA1 ADGRV1 NEB CSMD3 DSCAML1 NRXN1 APOB DNAH11 | 7.86e-10 | 184 | 200 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GABRB2 ABCA4 ABCA12 LAMA1 ADGRV1 NEB CSMD3 DSCAML1 NRXN1 APOB DNAH11 | 7.86e-10 | 184 | 200 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GABRB2 ABCA4 ABCA12 LAMA1 ADGRV1 NEB CSMD3 DSCAML1 NRXN1 APOB DNAH11 | 7.86e-10 | 184 | 200 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA4 ACTR3C LAMA1 LRRK2 DSCAML1 SKAP2 NEBL LAMB1 SNX29 PBX3 DNAH11 | 8.82e-10 | 186 | 200 | 11 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | KANSL1L ACTR3C LRRK2 NR6A1 DSCAML1 SERPINA1 NEBL LAMB1 NAALADL2 SLC16A5 MAPK10 | 1.62e-09 | 197 | 200 | 11 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SLC35D1 SCN7A FHL1 CNN1 SMCO3 CAMK2A LAMB1 SLIT3 CATSPERB GPR176 | 8.56e-09 | 178 | 200 | 10 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SLC35D1 SCN7A FHL1 CNN1 SMCO3 CAMK2A LAMB1 SLIT3 CATSPERB GPR176 | 8.56e-09 | 178 | 200 | 10 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SLC35D1 SCN7A FHL1 CNN1 SMCO3 CAMK2A LAMB1 SLIT3 CATSPERB GPR176 | 8.56e-09 | 178 | 200 | 10 | 35de8f791b0e78a6caf52ff095f05e204a59e828 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA4 ACTR3C LAMA1 LRRK2 ADGRV1 DSCAML1 SKAP2 NEBL LAMB1 SNX29 | 1.44e-08 | 188 | 200 | 10 | af740fa78542438fdff627ea1f74f4eee43316be |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | ACTR3C LRRK2 ADGRV1 ADGRF1 CCDC141 SUSD2 SNX25 CD36 MAPK10 SLC6A14 | 1.52e-08 | 189 | 200 | 10 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | KANSL1L ACTR3C LAMA1 LRRK2 NR6A1 NEBL LAMB1 NAALADL2 SNX29 MAPK10 | 2.14e-08 | 196 | 200 | 10 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | DOCK4 KANSL1L NR6A1 ADGRV1 PTK2 NEBL NAALADL2 SNX25 MAPK10 KIF13A | 2.36e-08 | 198 | 200 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-07 | 187 | 200 | 9 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-07 | 189 | 200 | 9 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.99e-07 | 189 | 200 | 9 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-07 | 190 | 200 | 9 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.27e-07 | 192 | 200 | 9 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | ACTR3C LRRK2 ADGRV1 ADGRF1 NEBL CCDC141 SNX25 MAPK10 SLC6A14 | 2.37e-07 | 193 | 200 | 9 | 738f4f0a9ddde2432b429ab46838e353b1790589 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-07 | 194 | 200 | 9 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.48e-07 | 194 | 200 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-07 | 194 | 200 | 9 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-07 | 194 | 200 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-07 | 195 | 200 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | KANSL1L ACTR3C NR6A1 DSCAML1 NEBL LAMB1 NAALADL2 SNX29 MAPK10 | 2.59e-07 | 195 | 200 | 9 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-07 | 196 | 200 | 9 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-07 | 196 | 200 | 9 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Epithelial_cells-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.82e-07 | 197 | 200 | 9 | 59aa28a377315dfcda4d9b6ecd3419157654f24e | |
| ToppCell | Severe-B_intermediate-10|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.94e-07 | 198 | 200 | 9 | dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-07 | 199 | 200 | 9 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-07 | 199 | 200 | 9 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.20e-07 | 200 | 200 | 9 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.20e-07 | 200 | 200 | 9 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.20e-07 | 200 | 200 | 9 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 3.20e-07 | 200 | 200 | 9 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.20e-07 | 200 | 200 | 9 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.47e-07 | 156 | 200 | 8 | 58b9520fce6e259b36c3d59e82b712f5e7729e3e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 170 | 200 | 8 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-06 | 174 | 200 | 8 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-CXCL9+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.30e-06 | 175 | 200 | 8 | 48f5bdbfc1ba40c3fb6411f12a69e61da2138296 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-06 | 178 | 200 | 8 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-06 | 179 | 200 | 8 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | CD8+_Memory_T_cell-FLU-5|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.54e-06 | 179 | 200 | 8 | 7f18dffa85285599662edbcd3f32ab42672bffb8 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 1.68e-06 | 181 | 200 | 8 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.68e-06 | 181 | 200 | 8 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.82e-06 | 183 | 200 | 8 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.82e-06 | 183 | 200 | 8 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-06 | 183 | 200 | 8 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.90e-06 | 184 | 200 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.90e-06 | 184 | 200 | 8 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-06 | 186 | 200 | 8 | 0b2ce9b8a4382d583240647217ad5e2d3fa555c1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 187 | 200 | 8 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 187 | 200 | 8 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.23e-06 | 188 | 200 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.32e-06 | 189 | 200 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-06 | 189 | 200 | 8 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-06 | 189 | 200 | 8 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-06 | 190 | 200 | 8 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.41e-06 | 190 | 200 | 8 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.41e-06 | 190 | 200 | 8 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-06 | 190 | 200 | 8 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-06 | 190 | 200 | 8 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.41e-06 | 190 | 200 | 8 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.51e-06 | 191 | 200 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.51e-06 | 191 | 200 | 8 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.60e-06 | 192 | 200 | 8 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.60e-06 | 192 | 200 | 8 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.71e-06 | 193 | 200 | 8 | 088c8b1e968f5356502347eaabdc6b1b1d4befd0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 193 | 200 | 8 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.71e-06 | 193 | 200 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.71e-06 | 193 | 200 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 2.81e-06 | 194 | 200 | 8 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 2.81e-06 | 194 | 200 | 8 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.81e-06 | 194 | 200 | 8 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 194 | 200 | 8 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.92e-06 | 195 | 200 | 8 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.92e-06 | 195 | 200 | 8 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 195 | 200 | 8 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-06 | 195 | 200 | 8 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-06 | 196 | 200 | 8 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-06 | 196 | 200 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-06 | 138 | 200 | 7 | a88c3ae56b0af60f6e87cabade4f21e2bbb336f2 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.15e-06 | 197 | 200 | 8 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 197 | 200 | 8 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-06 | 198 | 200 | 8 | 85215015bb86ada0e871c413a4ecdc903a3785ca | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.27e-06 | 198 | 200 | 8 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-06 | 198 | 200 | 8 | 38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.52e-06 | 200 | 200 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.52e-06 | 200 | 200 | 8 | 5c0135d3cb6f7fa904e9760904dfe5f11c7e9102 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.52e-06 | 200 | 200 | 8 | 26f07d271e984f375145e4c10528fba44a5811e1 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.52e-06 | 200 | 200 | 8 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.52e-06 | 200 | 200 | 8 | c3637827ceba16b0d7956c280dd2ddbc8b1ba55e | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.52e-06 | 200 | 200 | 8 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.52e-06 | 200 | 200 | 8 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.52e-06 | 200 | 200 | 8 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.52e-06 | 200 | 200 | 8 | 22892afca3666e944102c231b3f10340d8391364 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 3.52e-06 | 200 | 200 | 8 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.52e-06 | 200 | 200 | 8 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | proximal-3-mesenchymal-Vascular_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.52e-06 | 200 | 200 | 8 | 870ab11343711f64fe6d6a858fc420fe17f1636a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 3.52e-06 | 200 | 200 | 8 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-06 | 142 | 200 | 7 | 6469cf82552b39f63e20b841c9eed50de6f58d54 | |
| Computational | Genes in the cancer module 387. | 2.33e-05 | 49 | 128 | 6 | MODULE_387 | |
| Computational | Genes in the cancer module 201. | 2.62e-05 | 50 | 128 | 6 | MODULE_201 | |
| Computational | Genes in the cancer module 329. | 2.94e-05 | 51 | 128 | 6 | MODULE_329 | |
| Computational | Muscle genes. | 7.11e-05 | 37 | 128 | 5 | MODULE_512 | |
| Computational | Genes in the cancer module 202. | 3.15e-04 | 28 | 128 | 4 | MODULE_202 | |
| Drug | 3-mercaptopicolinate | 6.67e-07 | 36 | 200 | 6 | CID000119070 | |
| Drug | mildiomycin | 6.68e-07 | 3 | 200 | 3 | CID000125665 | |
| Drug | AOAA | 1.40e-06 | 91 | 200 | 8 | CID000000285 | |
| Drug | 5'-pCAA-3' | 1.77e-06 | 126 | 200 | 9 | CID000482140 | |
| Drug | pentenoic acid | 2.65e-06 | 4 | 200 | 3 | CID000012299 | |
| Drug | ureidoglycine | 2.65e-06 | 4 | 200 | 3 | CID000439649 | |
| Drug | N-acetylglutamate | 4.35e-06 | 49 | 200 | 6 | CID000000185 | |
| Drug | pyrroline-5-carboxylate | 7.75e-06 | 54 | 200 | 6 | CID000001196 | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.11e-05 | 199 | 200 | 10 | 5542_DN | |
| Drug | glutamate | GABRB2 NPL RIPK1 ASIC1 TRPC5 CLPX SUCLG2 PTK2 RYR1 SERPINA1 GLUD1 GLUD2 C2 PLCG2 UQCRC2 NRG2 GRIK1 GRIK2 CIT CBS ASS1 MAPK10 PC | 1.36e-05 | 962 | 200 | 23 | CID000000611 |
| Drug | magnesium | NPL ATP6V1A EIF4A3 LAMA1 PEPD PFKFB3 ADGRV1 CLPX SUCLG2 PSMA8 PTK2 PGM1 RYR1 LPIN1 SARS1 PELO C2 ZDHHC13 FARSB LAMB1 MYO1B GRIK1 ARF6 DNAH17 UHMK1 MAPK10 PC DNAH11 | 1.48e-05 | 1325 | 200 | 28 | CID000000888 |
| Drug | malate | 2.53e-05 | 219 | 200 | 10 | CID000000525 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.92e-05 | 178 | 200 | 9 | 5693_UP | |
| Drug | fluoroacetic acid | 4.11e-05 | 72 | 200 | 6 | CID000005236 | |
| Drug | hydroxypyruvate | 5.09e-05 | 46 | 200 | 5 | CID000000964 | |
| Drug | lactate | ASIC1 PFKFB3 ADGRV1 CLPX RYR1 GLUD1 GLUD2 SCN7A C2 UQCRC2 CIT SLC16A5 ASS1 PC | 6.15e-05 | 461 | 200 | 14 | CID000000612 |
| Drug | Ketoconazole [65277-42-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 6.43e-05 | 197 | 200 | 9 | 5685_UP | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | NCAM1 SERPINA1 DMWD CCDC33 DNAJC16 OGDHL CATSPERB PBX1 IL5RA | 6.43e-05 | 197 | 200 | 9 | 4315_UP |
| Drug | Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 4145_UP | |
| Drug | Salbutamol [18559-94-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 4700_UP | |
| Drug | sulfate | NPL MAN2A1 EIF4A3 LAMA1 PEPD PTGR2 NCAM1 SUCLG2 PTK2 PGM1 SLC35D1 AP2M1 GLUD1 SLC35A2 GLUD2 C2 PLCG2 MED17 SKAP2 HTATIP2 LAMB1 GRIK1 APOB CBS CD36 MAPK10 | 6.92e-05 | 1292 | 200 | 26 | CID000001117 |
| Drug | Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A | KANSL1L SLC35D1 FHL1 SLC16A5 IKBKE PDE4DIP ZNF76 GPR176 IL5RA | 6.95e-05 | 199 | 200 | 9 | 6828_UP |
| Drug | Aldehydes | NPL LAMA1 HAUS3 NEB DSCAML1 HMSD LPIN1 SEPTIN3 GOLGA7B CNN1 VSTM1 NECAB2 CIT MCTP1 PDE4DIP ASS1 OGDHL ZNF76 | 7.04e-05 | 720 | 200 | 18 | ctd:D000447 |
| Drug | S884 | 7.66e-05 | 10 | 200 | 3 | CID004685067 | |
| Drug | phenyltriethoxysilane | 7.68e-05 | 2 | 200 | 2 | CID000013075 | |
| Drug | G-3SH | 7.68e-05 | 2 | 200 | 2 | CID000174237 | |
| Drug | iodoacetyldiethylstilbestrol | 7.68e-05 | 2 | 200 | 2 | CID006455327 | |
| Drug | 0JO | 7.68e-05 | 2 | 200 | 2 | CID015942668 | |
| Drug | methylmercuric bromide | 7.68e-05 | 2 | 200 | 2 | CID000068175 | |
| Drug | 5-methylisophthalate | 7.68e-05 | 2 | 200 | 2 | CID000068137 | |
| Drug | 4-bromobiphenyl | 7.68e-05 | 2 | 200 | 2 | CID000007101 | |
| Drug | x 1 s | 7.68e-05 | 2 | 200 | 2 | CID000409694 | |
| Drug | 5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime | 7.68e-05 | 2 | 200 | 2 | ctd:C084273 | |
| Drug | UDP-N-acetylglucosamine | 8.10e-05 | 203 | 200 | 9 | CID000001167 | |
| Drug | glyceraldehyde-3-phosphate | 8.42e-05 | 159 | 200 | 8 | CID000000729 | |
| Disease | risky sexual behaviour measurement | 1.91e-05 | 169 | 197 | 8 | EFO_0007877 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.64e-05 | 145 | 197 | 7 | DOID:1289 (implicated_via_orthology) | |
| Disease | age-related hearing impairment | 6.99e-05 | 324 | 197 | 10 | EFO_0005782 | |
| Disease | fascioliasis (biomarker_via_orthology) | 1.32e-04 | 3 | 197 | 2 | DOID:885 (biomarker_via_orthology) | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 2.53e-04 | 46 | 197 | 4 | EFO_0005325, HP_0012735 | |
| Disease | Multiple pterygium syndrome | 2.64e-04 | 4 | 197 | 2 | C0265261 | |
| Disease | 4-hydroxyphenylpyruvate measurement | 2.64e-04 | 4 | 197 | 2 | EFO_0800120 | |
| Disease | FEV change measurement, response to glucocorticoid | 2.64e-04 | 4 | 197 | 2 | EFO_0005921, GO_0051384 | |
| Disease | Celiac Disease | 2.75e-04 | 47 | 197 | 4 | C0007570 | |
| Disease | Colorectal Carcinoma | ABCA4 ABCA12 LAMA1 CSMD3 DSCAML1 PGM1 LPIN1 SERPINB5 UQCRC2 LAMB3 MYO1B APOB NXN PREX2 | 2.85e-04 | 702 | 197 | 14 | C0009402 |
| Disease | descending aortic diameter | 3.15e-04 | 88 | 197 | 5 | EFO_0021788 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | GABRB2 CDH23 NCAM1 BIRC6 PTK2 CEMIP2 NRXN1 BEND7 RAB7A DOCK10 GRIK1 REV3L MCTP1 TTC29 PBX1 | 3.38e-04 | 801 | 197 | 15 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Bipolar Disorder | GABRB2 NCAM1 PFKFB3 SERPINA1 NRXN1 CLEC10A CAMK2A GRIK1 GRIK2 CBS PC | 3.89e-04 | 477 | 197 | 11 | C0005586 |
| Disease | response to bronchodilator, response to corticosteroid | 4.38e-04 | 5 | 197 | 2 | GO_0031960, GO_0097366 | |
| Disease | economic and social preference | 4.94e-04 | 97 | 197 | 5 | EFO_0004827 | |
| Disease | Coronary heart disease | 5.35e-04 | 24 | 197 | 3 | C0010068 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 6.54e-04 | 6 | 197 | 2 | C1854678 | |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 6.54e-04 | 6 | 197 | 2 | DOID:1825 (biomarker_via_orthology) | |
| Disease | response to diclofenac, drug-induced liver injury | 6.54e-04 | 6 | 197 | 2 | EFO_0004228, EFO_0007919 | |
| Disease | fatty acid measurement | ABCA4 PABPC4 DSCAML1 SERPINA1 EXOC6 MMS22L MYO1H APOB GRIK2 IL5RA | 7.44e-04 | 436 | 197 | 10 | EFO_0005110 |
| Disease | Endometrioma | 7.67e-04 | 161 | 197 | 6 | C0269102 | |
| Disease | Endometriosis | 7.67e-04 | 161 | 197 | 6 | C0014175 | |
| Disease | Intellectual Disability | GABRB2 EIF4A3 LAMA1 AP2M1 NRXN1 SLC35A2 CAMK2A FARSB UBR7 ASS1 | 8.98e-04 | 447 | 197 | 10 | C3714756 |
| Disease | 2-hydroxyphenylacetate measurement | 1.21e-03 | 8 | 197 | 2 | EFO_0800131 | |
| Disease | coffee consumption measurement | 1.44e-03 | 182 | 197 | 6 | EFO_0006781 | |
| Disease | cervical carcinoma | 1.44e-03 | 182 | 197 | 6 | EFO_0001061 | |
| Disease | FEV/FEC ratio | ABR VPS13C PABPC4 DCBLD1 CDH23 NCAM1 NEB PTK2 CEMIP2 SERPINA1 FBN1 SKAP2 NEBL KSR2 NPLOC4 PBX2 MAPK10 KIF13A | 1.55e-03 | 1228 | 197 | 18 | EFO_0004713 |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.93e-03 | 10 | 197 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.93e-03 | 10 | 197 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | 1,7-dimethylurate measurement | 1.93e-03 | 10 | 197 | 2 | EFO_0021512 | |
| Disease | Depression, Bipolar | 1.96e-03 | 79 | 197 | 4 | C0005587 | |
| Disease | smoking behavior | 2.17e-03 | 341 | 197 | 8 | EFO_0004318 | |
| Disease | response to radiation, breast carcinoma | 2.34e-03 | 11 | 197 | 2 | EFO_0000305, GO_0009314 | |
| Disease | Marfan Syndrome | 2.34e-03 | 11 | 197 | 2 | C0024796 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 2.80e-03 | 12 | 197 | 2 | EFO_0801493 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.80e-03 | 12 | 197 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | granulins measurement | 2.80e-03 | 12 | 197 | 2 | EFO_0008141 | |
| Disease | level of Ceramide (d42:2) in blood serum | 2.80e-03 | 12 | 197 | 2 | OBA_2045186 | |
| Disease | Congenital myopathy (disorder) | 2.80e-03 | 12 | 197 | 2 | C0270960 | |
| Disease | forced expiratory volume, response to bronchodilator | ADGRV1 SERPINA1 NRXN1 CLEC10A MMS22L KSR2 MCTP1 TTC29 CATSPERB | 3.17e-03 | 445 | 197 | 9 | EFO_0004314, GO_0097366 |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.26e-03 | 447 | 197 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 3.30e-03 | 13 | 197 | 2 | C1846647 | |
| Disease | visceral:gluteofemoral adipose tissue ratio measurement | 3.38e-03 | 45 | 197 | 3 | EFO_0803319 | |
| Disease | myopathy (implicated_via_orthology) | 4.06e-03 | 48 | 197 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | birth weight, pelvic organ prolapse | 4.31e-03 | 49 | 197 | 3 | EFO_0004344, EFO_0004710 | |
| Disease | Down syndrome (implicated_via_orthology) | 4.40e-03 | 15 | 197 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | African Burkitt's lymphoma | 4.40e-03 | 15 | 197 | 2 | C0343640 | |
| Disease | Burkitt Leukemia | 4.40e-03 | 15 | 197 | 2 | C4721444 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 4.40e-03 | 15 | 197 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | response to fenofibrate | 4.56e-03 | 50 | 197 | 3 | GO_1901557 | |
| Disease | serum metabolite measurement | NPL CFAP251 RIPK1 PSMD9 TXNDC16 PLCG2 DNAJC16 LAMB1 APOB GRIK2 REV3L CIT CBS DNAH17 | 4.64e-03 | 945 | 197 | 14 | EFO_0005653 |
| Disease | gastroesophageal reflux disease | 4.75e-03 | 101 | 197 | 4 | EFO_0003948 | |
| Disease | infant expressive language ability | 5.00e-03 | 16 | 197 | 2 | EFO_0006316 | |
| Disease | smoking status measurement | MAN2A1 PEPD NCAM1 BIRC6 PTK2 NRXN1 BEND7 RAB7A MMS22L MYO1B GRIK1 GRIK2 REV3L SNX29 MCTP1 TTC29 | 5.03e-03 | 1160 | 197 | 16 | EFO_0006527 |
| Disease | platelet measurement | 5.42e-03 | 315 | 197 | 7 | EFO_0005036 | |
| Disease | Mood Disorders | 5.51e-03 | 168 | 197 | 5 | C0525045 | |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 5.65e-03 | 17 | 197 | 2 | EFO_0008270 | |
| Disease | Dystonia, Limb | 5.65e-03 | 17 | 197 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 5.65e-03 | 17 | 197 | 2 | C0393610 | |
| Disease | peripheral arterial disease | 5.66e-03 | 54 | 197 | 3 | EFO_0004265 | |
| Disease | Hepatomegaly | 5.66e-03 | 54 | 197 | 3 | C0019209 | |
| Disease | Premature atrial contractions | 5.96e-03 | 55 | 197 | 3 | HP_0006699 | |
| Disease | Dystonia, Paroxysmal | 6.32e-03 | 18 | 197 | 2 | C0393588 | |
| Disease | adenosine monophosphate measurement | 6.32e-03 | 18 | 197 | 2 | EFO_0010454 | |
| Disease | Age-related macular degeneration | 6.32e-03 | 18 | 197 | 2 | cv:C0242383 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLASQLGVYKAFVDN | 176 | Q12979 | |
| FIEAQDLQGKDTYLK | 391 | A0FGR8 | |
| ESGNLQKVVKVAEYE | 176 | Q8NEM8 | |
| KVKAENGFQDNYSVV | 3901 | Q9NR09 | |
| KAGNVYKLTLDSQVV | 631 | Q9H7T0 | |
| SVGSVGFKVNYKEIE | 646 | Q7Z407 | |
| ARVVPNYKEFKVSQA | 406 | Q8N5R6 | |
| VGQSFAKKVLSVAVY | 181 | O76031 | |
| FYAQLKGKSQEEAQL | 1026 | P78363 | |
| KKAYERIQGFESVQV | 186 | Q5T601 | |
| TVNKAVALDTYEKGQ | 431 | Q9H9E3 | |
| VTKIYGSKVAVDNLN | 1351 | Q86UK0 | |
| QQQSVLDFLKAYGVE | 2161 | Q86UK0 | |
| FGDTEEAKKQINDYV | 171 | P01009 | |
| YTGINAINQKKFVID | 256 | Q9P1U1 | |
| ADDLAKQTKIEYGAV | 686 | P39086 | |
| FVAIGEFIYKSRKNN | 851 | P39086 | |
| GKNKSYDVRIENFDV | 171 | Q9NUQ8 | |
| NAERQLVVKDGATYK | 4816 | Q8WXG9 | |
| GKVDDFLQALINYDK | 3246 | Q96DT5 | |
| VGYAKVKITLINEND | 441 | Q9H251 | |
| FSAGQVQYLDLIKKD | 186 | Q09019 | |
| KFYLETQAGKLEAQN | 816 | O14578 | |
| KQVEIAQREGAKYVS | 101 | P00966 | |
| SFQEGAIIYVIKKND | 471 | Q9NYB9 | |
| DSYIVTGDIKGNIKF | 511 | Q8TBY9 | |
| GKQFSANDKVYTVEK | 456 | P36871 | |
| EGALIQFATYEEAKK | 571 | Q5T8P6 | |
| GKFTADQKAVYEAVL | 296 | P12955 | |
| AAGDVIKAAYNQVKT | 346 | P22695 | |
| TFIETRAKAGYNVKQ | 151 | Q9H0N0 | |
| TFIETRAKAGYNVKQ | 151 | Q53S08 | |
| QYKATIGADFLTKEV | 36 | P51149 | |
| GILNVDEFKKIYANF | 41 | P84074 | |
| IQEESKQFVARYGKV | 161 | Q8IXQ6 | |
| SEVNRGDKYIAKFQG | 21 | P33176 | |
| GKFQEEANIYAAKTA | 296 | P40424 | |
| NIGKFQEEANLYAAK | 296 | P40426 | |
| AELGAKAKEFTNVYI | 181 | Q13310 | |
| ENKFYKIEVQATDKG | 311 | Q9Y5I1 | |
| IGKFQEEANIYAVKT | 306 | P40425 | |
| EIKGNLAENKFVDEY | 656 | A0AUZ9 | |
| QISTVKEDAFQGLYK | 96 | O43300 | |
| DSEKKGFINKIYAIQ | 871 | Q6DN14 | |
| DKSSNFLYLQVKGEV | 136 | Q9BUP3 | |
| KSKVDNQFYSVEVGD | 41 | P53779 | |
| YKNKVEDSGIFTIKN | 736 | Q16706 | |
| EAKYIGSADFQAKEI | 391 | Q14439 | |
| YNSKQLEDFFKGGII | 116 | Q96S38 | |
| YAQKNLDIGVLAEKF | 581 | Q6ZRQ5 | |
| AVQVENEYGSFNKDK | 221 | Q8NCI6 | |
| VKTLNGFYAEAEKIG | 56 | Q2TAP0 | |
| NAINQKKFVIDVGYE | 131 | Q9C0K3 | |
| VFAKKNQGILEFYGD | 546 | P06681 | |
| DLKSKNVFYDNGKVV | 786 | Q6VAB6 | |
| ISAIQQGDKNKKFVY | 431 | Q8IYD8 | |
| KFVPKVDLQADYNTA | 401 | Q14164 | |
| YGRKGVAINFVKNDD | 371 | P38919 | |
| KLFTKDVLVQSNVYG | 696 | Q8NDZ0 | |
| SKNVFYDNGKVVITD | 736 | Q8IVT5 | |
| VQGKTKAEQFYRGDA | 371 | Q9ULD0 | |
| KYVFNSDGTVTNDKI | 881 | Q7Z5P9 | |
| VNKKEEIVGVATFYN | 391 | P16499 | |
| KSYLAKEGGQIAVFD | 111 | Q16875 | |
| YKDVDKFGNEITQLA | 426 | Q8TAT6 | |
| LQFNKVKVEDAGEYV | 296 | O14511 | |
| KDQLKAYGALTENVT | 446 | Q9Y2U5 | |
| VEKVTNKNYVRFLSG | 251 | Q9Y2G8 | |
| QLAGQVFVTVKELYK | 6 | Q14693 | |
| AAYEGEEVAVKIFNK | 1896 | Q5S007 | |
| VAIKGAFKVYFKQQQ | 246 | Q9NX47 | |
| KAAQNSGEAEYIEKV | 1661 | P07942 | |
| KVALYGKLVQSAQNE | 2016 | Q8NG31 | |
| KGDFVLQNEEASAKY | 406 | Q96PP9 | |
| FVYNTVNKIDQGAID | 126 | Q96PP8 | |
| DVNKIFYKDIKQNGT | 356 | P47870 | |
| LEGSAYIKVSIQKQA | 251 | Q9NVC6 | |
| AYFGKISEENIKNNF | 91 | Q96CW1 | |
| GAEYDNNKFKTTVVN | 1091 | P16885 | |
| KSADYVNLALKNGAV | 326 | Q9ULB1 | |
| AYAFALAGKEKQVES | 1131 | Q6IE36 | |
| EYGDDSIKKAQNVIN | 816 | Q9Y5B6 | |
| AAEGEIYTKLNQKID | 596 | Q8TAG9 | |
| QAQKTIVKETYGAFL | 686 | Q9UPT5 | |
| VKNVGREYLTAFTKN | 81 | O94913 | |
| KAIVAGDQNVEYKGT | 106 | Q13642 | |
| YKADTVAKVQGVEFS | 1851 | P04114 | |
| NIKDLFVTTNYEKAG | 381 | Q01344 | |
| EYALKKQQLTASVEG | 451 | Q6ZP82 | |
| LYADKFGADNVKIIQ | 1916 | Q96BY6 | |
| ILDENSQKYGSKVFD | 626 | Q8N1I0 | |
| GVYFIKTKSENINKD | 76 | Q9UFH2 | |
| EDDKGAFQLYSKAIQ | 286 | Q9UKT4 | |
| LKKFAQYGVVVQAFN | 1056 | Q8TD84 | |
| DGFFKINQKEGISYL | 2801 | P35555 | |
| NAIEKVFKVYNEAGV | 541 | P00367 | |
| VQITVTEGYDLKGFK | 11 | Q5T0N1 | |
| VYKVFNGKDNISKVA | 211 | P16671 | |
| NGKDNISKVAIIDTY | 216 | P16671 | |
| VDKRKTYIASFQNGI | 466 | Q9H336 | |
| SDQVGKVIYKQFKQI | 476 | P35520 | |
| VVKGDFDLQIAKQDY | 351 | Q68CZ6 | |
| KALAQREFYTVDGQK | 376 | Q9UHN6 | |
| KFYDVALDTGDKVVQ | 341 | Q9Y600 | |
| AQEGVKSYQSNAKVV | 476 | Q9NWL6 | |
| GKFYQATIKQLDFVN | 81 | A8MTL9 | |
| ALSAQEGFERIKQKY | 1071 | Q13751 | |
| DQNIVGAIKVFTEKY | 346 | Q8N7W2 | |
| FIDSNKVKYSIKGQD | 401 | Q8NDH2 | |
| SVLKEVYQAFNPKAV | 246 | Q9BY41 | |
| KNEVKNQIYPEADFA | 581 | A2RUR9 | |
| KTYKGIVNNEEKVFQ | 356 | Q8N8Z6 | |
| EYQLVQVEQKAGIKF | 546 | Q9NR30 | |
| ADDLAKQTKIEYGAV | 671 | Q13002 | |
| SKTVYAKDIQDVGAF | 476 | Q15835 | |
| DIGAKIAAVQFTYDQ | 401 | O43405 | |
| QAVFKFSALEGYVKV | 86 | Q99590 | |
| YSGKDVIEEQGKRNF | 3936 | P21817 | |
| KLKDIVGSEAFQDYV | 4066 | P21817 | |
| NVIDNKSGKVTAYDL | 551 | P54277 | |
| FQYSDGKLQTVAEKE | 851 | Q16531 | |
| NAIEKVFKVYSEAGV | 541 | P49448 | |
| KTLFGQNGKDEVVAY | 251 | Q99567 | |
| AVSLQNGKEYAVKII | 66 | Q9BUB5 | |
| ESNTTKYAGQEVVFK | 66 | Q9H1H9 | |
| YSKQIFGELADVTAK | 336 | Q15406 | |
| YLVKEQGVKNIFVNG | 36 | Q9BXD5 | |
| QIKANYDVLESQKGI | 36 | O00233 | |
| FAKTEAQKGAYIELT | 331 | P82650 | |
| SQFDEELYKVIGKGS | 241 | P49591 | |
| DQSYQFKTGAEVLKL | 131 | Q9GZN7 | |
| IIDSKNYAGQKDVQA | 251 | Q9UGT4 | |
| LNGEFGYQKLDVKSI | 331 | Q8TEQ0 | |
| DKQDIDKQYVGFATL | 16 | Q99719 | |
| ALYENLFKKEGFSNV | 736 | Q9BVQ7 | |
| LGEVFQNKDSDYLKN | 841 | Q5JRA6 | |
| VESYRKIKEAGQNFE | 216 | Q6DKJ4 | |
| DYLKVIDVQGKKNSF | 626 | Q9H3E2 | |
| KSIYLQEFQDKGDAE | 56 | O75563 | |
| NDKVYENVTGLVKAV | 921 | Q05397 | |
| AALVKEGYKVQSDVN | 2901 | P25391 | |
| TKVKVNFDNVGAGYL | 1396 | Q14524 | |
| QTKILVVNAAYFVGK | 156 | P36952 | |
| KVGNEYVTKGQTVDQ | 406 | P11055 | |
| RAFYGLKQVEKANEA | 291 | Q9BRX2 | |
| QFLKAAEDYGVIKTD | 96 | Q01995 | |
| VKVLAGQEYAAKIIN | 31 | Q9UQM7 | |
| VLTAANGAYVKQKLD | 196 | Q9NTN3 | |
| NTNFKEEPAAKYQAI | 561 | Q13546 | |
| FVQKYGLQSKAVEIL | 241 | P22307 | |
| NVKAAGASDVVLYKI | 51 | Q9NSD9 | |
| AVVVKYADNILKGFA | 286 | P78381 | |
| FGENGYVEATKQIIK | 411 | O95470 | |
| GFNVETVTYKNVKFN | 46 | P62330 | |
| AKKFNKSEQYIGENI | 391 | P78348 | |
| ENFQYLENKVKVQGF | 6 | Q8IUN9 | |
| DVNYNIVSKVALFQG | 951 | Q14028 | |
| ENIGNFIKAITKYGV | 86 | P51911 | |
| LGIFYFKKALQENDN | 311 | Q9H9A5 | |
| EVYVVAENQQGKSKA | 681 | P13591 | |
| YTVKDKATGEVLGQF | 421 | Q9BYT8 | |
| NFVGKDSYVELASAK | 1161 | O75094 | |
| DLLAVVFYGTEKDKN | 81 | P12956 | |
| GVKEAQVYQAFKLLT | 336 | Q96I99 | |
| ENYKNLVFLGVAVSK | 66 | Q8TF32 | |
| ENALKGKANIIFSYV | 151 | Q9P2K2 | |
| KQKVDFIDAYKSLGQ | 311 | Q8NBP0 | |
| TGKNFVSKIIAENIY | 106 | O14656 | |
| DLVKFYISKGAVVDQ | 96 | Q8IUH4 | |
| FYALQKKEQGKQAVA | 416 | O15375 | |
| KAAFITYLQAKQAAG | 3596 | Q96T58 | |
| YGFKVSIQNLQEAKA | 2276 | O60673 | |
| KIIDEGGYTKQQIFN | 171 | Q96MW7 | |
| FAVVGSDKEYQVNGK | 261 | Q9UH03 | |
| ELNVQKTVDYTGQAK | 246 | O75558 | |
| EEAQFETKKLYAGAI | 76 | O60613 | |
| VAKLIKDDFLQQNGY | 511 | P38606 | |
| KNGSQIDAVLDKLYV | 2036 | Q709C8 | |
| LKGQAVVRAFDQTKY | 1176 | Q70Z35 | |
| ADKESFEKAYQVGAV | 31 | Q86V86 | |
| GAVEKTQLQAAIKSY | 181 | A2RU48 | |
| VTFVLRKVNDSGYKQ | 56 | Q6UX27 | |
| LGELQKFQTAEKIYG | 76 | Q6ZN19 | |
| KFQTAEKIYGCNQIE | 81 | Q6ZN19 | |
| EVNFKGLSKEEVAAY | 46 | Q8NA56 | |
| DTVLAYENKGKIAQA | 336 | Q8N806 | |
| NFAYVKKEAGINDVS | 1401 | Q01118 | |
| FLNAVEKGDYATVKQ | 36 | Q9UL62 | |
| EKGDYATVKQALQEA | 41 | Q9UL62 | |
| DIVVLSKGYTKNDFA | 411 | Q8TB96 | |
| GHLFQVEYAQEAVKK | 16 | Q8TAA3 | |
| VEYAQEAVKKGSTAV | 21 | Q8TAA3 | |
| YIGAQSNFTKLKEAE | 296 | Q9UN76 | |
| LFQVEYAQEAVKKGS | 16 | O14818 | |
| GFDAAINYKKDNVAE | 201 | Q8N8N7 | |
| VKLAKQVGYENAGTV | 296 | P11498 | |
| SFKEGNQDVKYIQTD | 181 | Q8TAS1 | |
| TAYVQQAVKGEKLLE | 16 | P36508 | |
| TEVEENQKYFKGTLG | 371 | Q9NYU2 | |
| VFGANYIKGTVKAEA | 86 | Q969T9 | |
| AGKVLYQVEGFVDKN | 516 | O43795 | |
| VFDTGLEEQVYKNKN | 1006 | Q8N1T3 | |
| AQVYFKAGLDVFKSV | 776 | Q58DX5 | |
| GNAKVNYIFNEKEIF | 1271 | P52179 | |
| LGKQEEFRVYGKSEN | 1336 | Q5VU43 | |
| TQQNISAVFYKKEVG | 586 | O76041 | |
| ALSDVAYKKGLAEQQ | 236 | P20929 | |
| QENISSVLYKENVGK | 6301 | P20929 | |
| FRKQIQGKAAYVLDT | 6406 | P20929 | |
| TKKVYEGGSNVDQFV | 151 | Q7Z6G3 |